BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19107233)

  • 1. Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.
    Wu Z; Cho H; Hampton GM; Theodorescu D
    Neoplasia; 2009 Jan; 11(1):66-76. PubMed ID: 19107233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators.
    van Duijn PW; Ziel-van der Made AC; van der Korput JA; Trapman J
    Prostate; 2010 Feb; 70(2):135-46. PubMed ID: 19784964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of Cdc6, a cell cycle regulatory gene, in prostate cancer.
    Robles LD; Frost AR; Davila M; Hutson AD; Grizzle WE; Chakrabarti R
    J Biol Chem; 2002 Jul; 277(28):25431-8. PubMed ID: 12006585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
    Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
    Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells.
    Wu Z; Conaway M; Gioeli D; Weber MJ; Theodorescu D
    Prostate; 2006 Jul; 66(10):1114-23. PubMed ID: 16637073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.
    Modur V; Nagarajan R; Evers BM; Milbrandt J
    J Biol Chem; 2002 Dec; 277(49):47928-37. PubMed ID: 12351634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PTEN in prostate cancer cell tropism to the bone micro-environment.
    Wu Z; McRoberts KS; Theodorescu D
    Carcinogenesis; 2007 Jul; 28(7):1393-400. PubMed ID: 17347137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate.
    Desai KV; Michalowska AM; Kondaiah P; Ward JM; Shih JH; Green JE
    Mol Endocrinol; 2004 Dec; 18(12):2895-907. PubMed ID: 15358834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
    Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.
    Shoulars K; Rodriguez MA; Thompson T; Markaverich BM
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):41-50. PubMed ID: 19837161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells.
    Liu Y; Gong Z; Sun L; Li X
    Biochim Biophys Acta; 2014; 1839(4):297-305. PubMed ID: 24583551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells.
    Mallik I; Davila M; Tapia T; Schanen B; Chakrabarti R
    Biochim Biophys Acta; 2008 Oct; 1783(10):1737-44. PubMed ID: 18541154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
    Sun A; Shanmugam I; Song J; Terranova PF; Thrasher JB; Li B
    Prostate; 2007 Jun; 67(9):976-88. PubMed ID: 17440966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
    Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
    Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.
    Yu EJ; Hooker E; Johnson DT; Kwak MK; Zou K; Luong R; He Y; Sun Z
    PLoS One; 2017; 12(3):e0174357. PubMed ID: 28323888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.